EUVIMEDEUVIMED entdecken
Crossref

Assessment of temporal changes in cognitive effects induced by antiseizure medications in epilepsy patients

Ömer Karadaş, Javid Shafiyev, Akçay Övünç Karadaş, Uğur Burak Şimşek, Betül Özenç, Özlem Aksoy Özmenek

Epilepsy & Behavior · 2025

DOI: 10.1016/j.yebeh.2024.110199 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Epilepsy & Behavior, 2025. Verfasst von Ömer Karadaş und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurology, Gulhane Faculty of Medicine, Health Sciences University, Etlik, Orgeneral Dr. Tevfik Sağlam Cd No:1, 06010 Kecioren, Ankara,…. Hauptthemen laut MEDLINE: Anticonvulsants, Epilepsy, Cognitive Dysfunction, Evoked Potentials. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 34 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

OBJECTIVE: Numerous studies have been conducted investigating the effects of antiseizure medications (ASMs) on cognitive functions, and the cognitive side effects of some ASMs have been demonstrated. However, data on whether tolerance to these side effects develops over time is insufficient. The aim of this study is to evaluate the reversibility of cognitive impairments caused by ASMs in patients, utilizing event-related potentials (ERPs) and the Montreal Cognitive Assessment (MoCA) test. MATERIALS AND METHODS: The single-center prospective study was conducted from July 2022 to August 2023. This study enrolled participants aged 18 to 50 who had been diagnosed with epilepsy and were planning to commence treatment with an antiseizure medication (ASM). The inclusion criteria comprised individuals aged between 18 and 50 years, with a diagnosis of epilepsy, and who were intending to initiate a new ASM as monotherapy. Exclusion criteria encompassed individuals younger than 18 or older than 50 years, those diagnosed with psychogenic non-epileptic seizures, those currently on antiepileptic drugs, and those with cognitive dysfunction or dementia. Before starting treatment, patients were subjected to the MoCA test and ERP measurements by a neurologist. These tests and measurements were repeated at the second and sixth months of treatment. RESULT: The study included a cohort of 254 participants with a mean age of 32.6 (±14) years. At the second month after starting treatment with carbamazepine (CBZ), zonisamide (ZNS), valproic acid (VPA), and topiramate (TPM), both MoCA and ERP values showed significantly worse cognitive impairment compared to before treatment (p < 0.05). This impairment showed a significant improvement by the sixth month for CBZ, ZNS, and VPA (p < 0.05). Although there was improvement in MoCA and ERP values in patients using TPM, the changes remained statistically significant compared to baseline values (p < 0.05). In patients using levetiracetam, lamotrigine, oxcarbazepine, and lacosamide, cognitive impairment was not statistically significant at either the second or sixth month. CONCLUSION: This study demonstrated that the detrimental cognitive effects associated with CBZ, VPA, and ZNS could be reversible. Although some improvement was observed over time with TPM, the absence of significant recovery suggests that additional time may be required for a substantial reversal of these effects.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

AnticonvulsantsEpilepsyCognitive DysfunctionEvoked PotentialsCognitionHumansAdultMaleFemaleMiddle AgedYoung AdultProspective StudiesAdolescentMental Status and Dementia TestsElectroencephalography

Stichwörter der Autor:innen

Antiseizure medicationCognitivie impairmentMoCAN200P300

Substanzen

Anticonvulsants

Autor:innen und Institutionen

  • Department of Neurology, Gulhane Faculty of Medicine, Health Sciences University, Etlik, Orgeneral Dr. Tevfik Sağlam Cd No:1, 06010 Kecioren, Ankara, Turkey. Electronic address: dromerkaradas@gmail.com.
  • Department of Neurology, Gülhane Training and Research Hospital, Etlik, Orgeneral Dr. Tevfik Sağlam Cd No:1, 06010 Kecioren, Ankara, Turkey.
  • Private Clinic, Kızılırmak Mahallesi, Ufuk Üniversitesi Caddesi, Arma Kule 11/B Kat:15 Cankaya/Ankara, Turkey.
  • Gaziantep City Hospital Neurology Clinic, İbn-i Sina Mahallesi, 27470 Sahinbey, Gaziantep, Turkey.
  • Liv Hospital Neurology Department, Kavaklıdere, Bestekar Cd No:8, 06680 Cankaya, Ankara, Turkey.

Zitieren

APA

Karadaş, Ö., Shafiyev, J., Karadaş, A. Ö., Şimşek, U. B., Özenç, B., & Özmenek, Ö. A. (2025). Assessment of temporal changes in cognitive effects induced by antiseizure medications in epilepsy patients. Epilepsy & Behavior. https://doi.org/10.1016/j.yebeh.2024.110199

Vancouver

Karadaş Ö, Shafiyev J, Karadaş AÖ, Şimşek UB, Özenç B, Özmenek ÖA. Assessment of temporal changes in cognitive effects induced by antiseizure medications in epilepsy patients. Epilepsy & Behavior. 2025. doi:10.1016/j.yebeh.2024.110199

BibTeX
@article{Karada2025,
  author = {Karadaş, Ömer and Shafiyev, Javid and Karadaş, Akçay Övünç and Şimşek, Uğur Burak and Özenç, Betül and Özmenek, Özlem Aksoy},
  title = {Assessment of temporal changes in cognitive effects induced by antiseizure medications in epilepsy patients},
  journal = {Epilepsy & Behavior},
  year = {2025},
  doi = {10.1016/j.yebeh.2024.110199}
}
Kostenlos starten →